3 different ACL reconstruction techniques displayed similar loss in bone mineral density .
This report has been verified
by one or more authors of the
original publication.
OrthoEvidence Journal (OE Journal) - ACE Report
OE Journal. 2013;1(12):239 Knee. 2012 Dec;19(6):779-85. doi: 10.1016/j.knee.2012.02.005. Epub 2012 Mar 1662 male adult patients undergoing ACL reconstruction (ACLR) were randomized to either bone-patella tendon-bone (BPTB) graft, single-bundle hamstring (HT-SB) graft, or double-bundle hamstring (HT-DB) graft techniques. Changes in bone mineral density (BMD) of the three different ACLR techniques were measured at 1 day, 3 months, 5 months, and 1 year post-operation. Similar results were seen in the three ACLR techniques in terms of bone loss at the knee region, irreversible bone loss at the hip, and early clinical and functional outcomes up to 1 year after surgery. Additionally, a positive correlation existed between BMD at the distal femur and single-leg hop distance a 1 year post-operation.
Was the allocation sequence adequately generated?
Was allocation adequately concealed?
Blinding Treatment Providers: Was knowledge of the allocated interventions adequately prevented?
Blinding Outcome Assessors: Was knowledge of the allocated interventions adequately prevented?
Blinding Patients: Was knowledge of the allocated interventions adequately prevented?
Was loss to follow-up (missing outcome data) infrequent?
Are reports of the study free of suggestion of selective outcome reporting?
Were outcomes objective, patient-important and assessed in a manner to limit bias (ie. duplicate assessors, Independent assessors)?
Was the sample size sufficiently large to assure a balance of prognosis and sufficiently large number of outcome events?
Was investigator expertise/experience with both treatment and control techniques likely the same (ie.were criteria for surgeon participation/expertise provided)?
Sí = 1
Incierto = 0,5
No relevante = 0
No = 0
La evaluación de los criterios de información evalúa la transparencia con la que los autores informan de las características metodológicas y del ensayo dentro de la publicación. La evaluación se divide en cinco categorías que se presentan a continuación.
3/4
Randomization
3/4
Outcome Measurements
4/4
Inclusion / Exclusion
4/4
Therapy Description
4/4
Statistics
Detsky AS, Naylor CD, O'Rourke K, McGeer AJ, L'Abbé KA. J Clin Epidemiol. 1992;45:255-65
El Índice de Fragilidad es una herramienta que ayuda en la interpretación de hallazgos significativos, proporcionando una medida de fuerza para un resultado. El Índice de Fragilidad representa el número de eventos consecutivos que es necesario añadir a un resultado dicotómico para que el hallazgo deje de ser significativo. Un número pequeño representa un hallazgo más débil y un número grande un hallazgo más fuerte.
¿Por qué se necesitaba ahora este estudio?
Multiple studies have shown that after ACL reconstruction using BPTB graft, there can be a significant decrease in BMD around the knee region. However, many of these studies were neither randomized nor controlled, causing uncertainty in the reliability of the results. Additionally, none of these studies assessed BMD in HT-SB or HT-DB graft ACL reconstruction. This trial aimed to determine whether changes in BMD varied significantly between the ACL reconstruction techniques and elucidate the impact of BMD on the early functional or clinical outcomes.
¿Cuál era la pregunta principal de la investigación?
Did BMD change around the knee region differ depending on the type of ACL reconstruction technique (BPTB, HT-SB, HS-DB) and did BMD loss at the knee region have a negative impact on the recovery of patients post-surgery when examined over a 1 year period?
- BMD at both the distal femur and proximal tibia decreased significantly at month 3 post-op (distal femur: -6.5% +/-6.9%; proximal tibia: -4.8% +/-7.0%) and month 5 post-op (distal femur: -7.3% +/-10.1%; proximal tibia: -5.6% +/-12.6%), increased and became insignificantly different from day 1 at 1 year post-op (distal femur: -1.6% +/-10.3%; proximal tibia: 0% +/-13.0%).
- There was no significant difference in BMD loss at the distal femur and proximal tibia among the three surgical techniques (p=0.205 and 0.121, respectively).
- There was significant irreversible loss of BMD at both the trochanteric region (month 3: -3.6% +/-3.3%; month 5: -4.5% +/-8.2%; 1 year: -4.2% +/-6.2%) and the femoral neck (month 3: -1.9% +/-3.7%; month 5: -2.4% +/-8.3%; 1 year: -2.5% +/-6.8%) of the injured limb.
- There was no significant difference in BMD loss among the three surgical techniques at the trochanteric region and femoral neck.
- At 1 year post-op, there were no significant differences between the different surgical techniques in IKDC score (p=0.759), Lysholm score (p=0.541), single-leg hop distance ratio (p=0.504), KT-1000 side-to-side difference (p=0.120), and manual Lachman test score (p=0.477)
- After combining data from the different groups, at 1 year post-op there was a significant improvement from baseline in IKDC score, Lysholm score, single-leg hop distance ratio, KT-1000 side-to-side difference, and manual Lachman test score (all p<0.001)
- Between BMD at the distal femur and the single-leg hop distance of the injured limb at 1 year post-op, a significant positive correlation was observed (r=0.299, p=0.031)
¿Qué es lo que más debo recordar?
The results indicated that BMD loss was similar between BPTB graft, HT-SB graft, and HT-DB graft ACL reconstruction techniques. Additionally, early clinical and functional outcomes were similar among the three groups. As well, BMD at the distal femur and the single-leg hop distance a 1 year post-operation were positively related to one another.
¿Cómo afectará esto al cuidado de mis pacientes?
There appear to be no significant differences in BMD following these three types of ACL reconstruction in male patients. Further research is required to determine changes of BMD in female patients who have undergone different types of ACL reconstruction and if the type of rehabilitation has an effect. Moreover, the use of other high-resolution bone imaging systems, such as XtremeCT for in vivo BMD measurement can be incorporated in future studies in order to provide more data.
DESCARGO DE RESPONSABILIDAD
El contenido de esta página tiene únicamente fines informativos y no pretende sustituir el consejo, diagnóstico o tratamiento médico profesional. Si necesita tratamiento médico, busque siempre el consejo de su médico o acuda al servicio de urgencias más cercano. Las opiniones, creencias y puntos de vista expresados por las personas sobre el contenido que se encuentra en esta página no reflejan las opiniones, creencias y puntos de vista de OrthoEvidence.
